AUTONOMIX MEDICAL, INC.

Other languages Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Market Closed - Nasdaq Other stock markets 03:59:51 2024-06-11 pm EDT			5-day change	1st Jan Change
1.17 ^USD	-5.65%		-40.00%	0.00%

Jun. 03	Autonomix Medical, Inc. Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial	CI
May. 31	Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Autonomix Medical, Inc. Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial	Jun. 03
Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	May. 31
Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip	Apr. 25
Autonomix Medical, Inc. Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation	Apr. 09
Autonomix Appoints Jennifer Cook as Chief Business Officer	Mar. 19
Autonomix Medical, Inc. Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	Mar. 14
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	Mar. 06
Autonomix Medical, Inc. Secures Principal Investigators and Completes Clinical Training for First Human Study	Feb. 22
Autonomix Medical, Inc. Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	Feb. 16
Autonomix Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Earnings Overshadow Potential Bond Surge Concerns	Feb. 07
Top Premarket Gainers	Feb. 07
Autonomix Gets Approval to Start Clinical Trial for Pancreatic Cancer Pain Treatment in Uzbekistan	Feb. 06
Autonomix Re-Acquires Sensing Technology from Impulse Medical for $8 Million in Stock	Jan. 30
Autonomix Medical, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	Jan. 09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer